Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma

Overview of attention for article published in Journal of Neuro-Oncology, November 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 8,387 followers.

RT @LOOPSproject: Phase II study of tivozanib in patients with recurrent glioblastoma: https://t.co/iWvPb32vtY @MGHImaging @MGHMartinos @OU…

Phase II study of tivozanib in patients with recurrent glioblastoma: https://t.co/iWvPb32vtY @MGHImaging @MGHMartinos @OUSForsk